Biote Corporation - BTMD Real Price to Acquire Entire Company

Biote Corporation - graphic logo of issuer BTMD

This daily price chart for biote Corp. (BTMD) reflects a business valuation of 167.47. biote Corp. leads the bioidentical hormone therapy segment, establishing resilient B2B sales channels with predictable cash flow. High product quality is ensured by GMP-certified facilities with optimal equipment wear. Business development relies on an expert staff of physicians specializing in longevity and professional training.

BTMD biote.com Real Price to Acquire Entire Company (11/23/2025 - 10/28/2026)

Financial and market metric breakdowns for biote Corp. (BTMD)

- price and consensus price forecast:
Price Biote|BTMD - Price Target Chart
- market capitalization data:
Market Valuation biote Corp.|BTMD - Enterprise Value
- book capitalization data:
Equity per Share biote Corp.|BTMD - Company Net Assets|Market Cap to Book Value Multiple biote.com|BTMD - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio biote Corp.|BTMD - Long-Term Debt to Capital|Current Liabilities to Capital biote.com|BTMD - Company Aggregate Debts|Debts to Book Capitalization biote Corp.|BTMD - Company Long-Term Liabilities|Amount of Current Liabilities biote Corp.
Summary company analytics:BTMD - Biote
Original product of Biote Corp

Effective distribution of hormone therapies and warehouse management at biote Corp. (BTMD) require significant capital expenditures, making the calculation of business value via the sum of capitalization and debt minus liquid assets critical for assessing the real acquisition price. Analyzing the total capital metric allows an investor to filter out market noise and determine the true cost of scaling the company's operational infrastructure.

Competitors of biote Corp.

HCA Inc. - Aggregate Business Value|THC: Total Company Value|FMS - Real Price to Acquire Entire Company|Enterprise Value Solventum Corporation|Business Value encompasshealth.com|Universal Health Services Inc (UHS) - Real Price to Acquire Entire Company|Aggregate Business Value DVA|RadNet Corp (RDNT) - Total Company Value|Value Adjusted for Debt and Cash Option Care Corp (OPCH)|SGRY: Enterprise Value|Total Enterprise Value premierinc.com PINC|National Vision - Enterprise Value|Progyny Inc (PGNY) - Enterprise Value|ARDT - Real Price to Acquire Entire Company|SEM (Select Medical Inc.) - Aggregate Business Value|Total Company Value ASTH|Real Price to Acquire Entire Company MEDNAX|U.S. Physical Therapy - Enterprise Value|Total Enterprise Value PNTG (Pennant Group)|ORGO - Total Company Value|NUTX - Business Value|Real Price to Acquire Entire Company Auna SA AUNA|SBC - Aggregate Business Value|Evolus (EOLS) - Enterprise Value|CHS (CYH) - Total Company Value|SKIN: Enterprise Value|Company Buyout Price MDWD|The Joint Corp. - Total Company Value|Total Enterprise Value docgo.com DCGO|Real Price to Acquire Entire Company P3 Health Partners (PIII)|Aggregate Business Value gaintherapeutics.com GANX|EUDA (EUDA Health Holdings Limited) - Enterprise Value|Basel Medical Group (BMGL) - Total Enterprise Value|Real Price to Acquire Entire Company collplant.com CLGN|cuprina.com.sg (CUPR) - Value Adjusted for Debt and Cash|Enterprise Value CCM|Real Price to Acquire Entire Company AMS|MEDIROM Healthcare Group Inc - Total Company Value|Total Enterprise Value ALBT (avalon-globocare.com)|Total Company Value DIH Holding US, Inc.|carmellcosmetics.com - Value Adjusted for Debt and Cash|Total Company Value NewGenIvf|ATI Physical Therapy (ATIP) - Full Business Value|CareMax Medical Group - Real Price to Acquire Entire Company|Kindly Health (KDLY) - Company Buyout Price|Enterprise Value ModivCare Inc.|Total Company Value novointegrated.com (NVOS)|Real Price to Acquire Entire Company SunLink Health Systems|Aggregate Business Value BACK (IMAC Holdings Inc)